MedCap AB (publ) (STO:MCAP)
Sweden · Delayed Price · Currency is SEK 654.00
+1.00 (0.15%)
Aug 1, 2025, 5:29 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Medtech Revenue (Pre-Q3 2023 Reporting) | - | Log In | Log In | Log In | Log In | Upgrade |
Medtech Revenue (Pre-Q3 2023 Reporting) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Specialty Pharma | 431.80M | Log In | Log In | Log In | Log In | Upgrade |
Specialty Pharma Growth | -12.13% | Log In | Log In | Log In | Log In | Upgrade |
Other | 500.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Assistive Tech | 767.20M | Log In | Log In | Log In | Log In | Upgrade |
Assistive Tech Growth | 24.58% | Log In | Log In | Log In | Log In | Upgrade |
Medtech Revenue (Post-Q2 2023 Reporting) | 607.70M | Log In | Log In | Log In | Log In | Upgrade |
Medtech Revenue (Post-Q2 2023 Reporting) Growth | 8.51% | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals | 420.50M | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceuticals Growth | -13.81% | Log In | Log In | Log In | Log In | Upgrade |
Assistive Technology | 765.90M | Log In | Log In | Log In | Log In | Upgrade |
Assistive Technology Growth | 24.59% | Log In | Log In | Log In | Log In | Upgrade |
Medical Devices | 322.70M | Log In | Log In | Log In | Log In | Upgrade |
Medical Devices Growth | 6.70% | Log In | Log In | Log In | Log In | Upgrade |
Nutrition & Other Food | 251.80M | Log In | Log In | Log In | Log In | Upgrade |
Nutrition & Other Food Growth | 15.89% | Log In | Log In | Log In | Log In | Upgrade |
Other Product | 45.90M | Log In | Log In | Log In | Log In | Upgrade |
Other Product Growth | -3.98% | Log In | Log In | Log In | Log In | Upgrade |
Other | 500.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | 500.00K | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Other | -31.40M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Medtech Operating Profit (Pre-Q3 2023 Reporting) | - | Log In | Log In | Log In | Log In | Upgrade |
Medtech Operating Profit (Pre-Q3 2023 Reporting) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Specialty Pharma Operating Profit | 33.40M | Log In | Log In | Log In | Log In | Upgrade |
Specialty Pharma Operating Profit Growth | -69.68% | Log In | Log In | Log In | Log In | Upgrade |
Other and Eliminations from Operating Profit | -23.90M | Log In | Log In | Log In | Log In | Upgrade |
Other and Eliminations from Operating Profit Growth | -4.96% | Log In | Log In | Log In | Log In | Upgrade |
Other | -31.40M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Assistive Tech Operating Profit | 164.10M | Log In | Log In | Log In | Log In | Upgrade |
Assistive Tech Operating Profit Growth | 4.34% | Log In | Log In | Log In | Log In | Upgrade |
Medtech Operating Profit (Post-Q2 2023 Reporting) | 98.70M | Log In | Log In | Log In | Log In | Upgrade |
Medtech Operating Profit (Post-Q2 2023 Reporting) Growth | 18.94% | Log In | Log In | Log In | Log In | Upgrade |
Other | -31.40M | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
EBITDA by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting) | - | Log In | Log In | Log In | Log In | Upgrade |
Medtech Adjusted EBITDA (Pre-Q3 2023 Reporting) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Specialty Pharma Adjusted EBITDA | 59.20M | Log In | Log In | Log In | Log In | Upgrade |
Specialty Pharma Adjusted EBITDA Growth | -52.02% | Log In | Log In | Log In | Log In | Upgrade |
Other and Eliminations from Adjusted EBITDA | -21.70M | Log In | Log In | Log In | Log In | Upgrade |
Other and Eliminations from Adjusted EBITDA Growth | 0% | Log In | Log In | Log In | Log In | Upgrade |
Assistive Tech Adjusted EBITDA | 212.00M | Log In | Log In | Log In | Log In | Upgrade |
Assistive Tech Adjusted EBITDA Growth | 11.31% | Log In | Log In | Log In | Log In | Upgrade |
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting) | 138.30M | Log In | Log In | Log In | Log In | Upgrade |
Medtech Adjusted EBITDA (Post-Q2 2023 Reporting) Growth | 17.51% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Sweden | 898.40M | Log In | Log In | Log In | Log In | Upgrade |
Sweden Growth | 1.99% | Log In | Log In | Log In | Log In | Upgrade |
Nordic (ex-Sweden) | 448.60M | Log In | Log In | Log In | Log In | Upgrade |
Nordic (ex-Sweden) Growth | 27.36% | Log In | Log In | Log In | Log In | Upgrade |
Europe (ex-Nordic) | 384.70M | Log In | Log In | Log In | Log In | Upgrade |
Europe (ex-Nordic) Growth | 7.87% | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World | 75.10M | Log In | Log In | Log In | Log In | Upgrade |
Rest of the World Growth | 6.07% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |